Acetylator status of kwashiorkor children in Ibadan (south-west Nigeria)
- PMID: 2384118
- DOI: 10.1007/BF03190128
Acetylator status of kwashiorkor children in Ibadan (south-west Nigeria)
Abstract
Acetylator status was determined in 25 kwashiorkor children, aged between 8 months and 3 years and in 25 age-matched control group of healthy children after a single oral dose of sulphamethazine (40 mg/kg body weight) and by measuring the acetylated sulphamethazine in blood samples, collected 6 h after the administration of sulphamethazine. The percentage of slow acetylators among kwashiorkor children was 40% while among the control group of children it was 48%. The difference between the two groups was not significant. Therefore, it is probable that the slow acetylator status of the Nigerian African children may not be a contributing factor for the development of kwashiorkor, a syndrome of protein-energy malnutrition. Furthermore, the polymorphic activity of N-acetyl transferase enzyme may not be impaired in kwashiorkor.
Similar articles
-
Polymorphic acetylation of sulphamethazine in man: acetylator phenotype in sicklers and non-sicklers.Toxicol Lett. 1980 Sep;6(4-5):263-5. doi: 10.1016/0378-4274(80)90130-7. Toxicol Lett. 1980. PMID: 7423555
-
N-acetylation in healthy and diseased children.Eur J Clin Pharmacol. 1990;39(1):43-7. doi: 10.1007/BF02657055. Eur J Clin Pharmacol. 1990. PMID: 2276387
-
Acetylator polymorphism in Parkinson's disease.Eur J Clin Pharmacol. 1989;37(4):391-3. doi: 10.1007/BF00558506. Eur J Clin Pharmacol. 1989. PMID: 2598972
-
Genetically determined variability in acetylation and oxidation. Therapeutic implications.Drugs. 1985 Apr;29(4):342-75. doi: 10.2165/00003495-198529040-00003. Drugs. 1985. PMID: 2859977 Review.
-
Acetylation.Birth Defects Orig Artic Ser. 1990;26(1):43-65. Birth Defects Orig Artic Ser. 1990. PMID: 2224079 Review.
Cited by
-
Comparison of CYP1A2 and NAT2 phenotypes between black and white smokers.Biochem Pharmacol. 2008 Oct 1;76(7):929-37. doi: 10.1016/j.bcp.2008.07.024. Epub 2008 Jul 25. Biochem Pharmacol. 2008. PMID: 18703023 Free PMC article. Clinical Trial.